Last year, Zhengye Biotechnology Holding Ltd generated 90.14M USD for its biggest-performing segment, Swine vaccines. The China (Mainland) made the largest contribution, accounting for 116.36M USD last year.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Swine vaccines

Other vaccines

Poultry vaccines

Swine vaccines

Poultry vaccines

Other vaccines

FY2025

FY2024

Swine vaccines

90.14M(77.47%)

--(--)

Other vaccines

13.74M(11.81%)

--(--)

Poultry vaccines

12.48M(10.73%)

--(--)

Swine vaccines

--(--)

157.79M(84.67%)

Poultry vaccines

--(--)

15.51M(8.32%)

Other vaccines

--(--)

13.06M(7.01%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

China (Mainland)

FY2025

FY2024

China (Mainland)

116.36M(100.00%)

186.36M(100.00%)